Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 21, 2024
BOSTON and LONDON, May 21, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:
